SEC Form 4 · accession 0001209191-15-022263
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy Macdonald
Officer — President and Chief Executive · Director
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 2, 2015 | M | 10,000 | $7.94 | A | 60,537 | D | |
| Common StockF1 | Mar 2, 2015 | S | 200 | $38.90 | D | 60,337 | D | |
| Common StockF1,F3 | Mar 2, 2015 | S | 9,800 | $39.67 | D | 50,537 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F4 | $7.94 | Mar 2, 2015 | M | 10,000 | D | — | May 14, 2023 | Common Stock | 10,000 | 240,000 | D |
Explanation of responses
- F1The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2014.
- F2The amount of securities beneficially owned by the reporting person following the transaction reported on this Form 4 reflects the purchase by the reporting person of 537 shares of common stock on November 17, 2014 under the Tetraphase Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan (the "ESPP"). The shares purchased under the ESPP were inadvertently omitted from the amount of securities beneficially owned that were reported in the Form 4's filed by the reporting person on January 9, 2015, January 22, 2015 and February 4, 2015.
- F3The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $39.17 to $40.05 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4Vested as to 25% of the original number of shares granted on 5/15/2014 and further vests as to an additional 6.25% of the original number of shares granted at the end of each successive three-month period thereafter until 5/15/2017.